These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4544515)

  • 21. Pathology of demyelination and remyelination.
    Ludwin SK
    Adv Neurol; 1981; 31():123-68. PubMed ID: 7325040
    [No Abstract]   [Full Text] [Related]  

  • 22. [My understanding of multiple sclerosis at the present time].
    Yonezawa T
    Nihon Rinsho; 1970 Sep; 28(9):2230-4. PubMed ID: 5466655
    [No Abstract]   [Full Text] [Related]  

  • 23. [Encephalomyelitis disseminata (also called multiple sclerosis)].
    Meyer G
    Fortschr Med; 1973 May; 91(13):559-62 contd. PubMed ID: 4701124
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the clinic-anatomic characteristic of the sub-acute form of multiple sclerosis. Once again about integrative viral conception of the origin of demyelinating diseases].
    Bogorodinskiĭ DK; Barantsevich RP; Astakhova VV
    Vopr Psikhiatr Nevropatol; 1966; 12():80-9. PubMed ID: 5991558
    [No Abstract]   [Full Text] [Related]  

  • 25. [Demyelinating diseases].
    Escourolle R; Poirier J
    Presse Med (1893); 1971 Jan; 79(5):203-8. PubMed ID: 5546782
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complement fixation reactions with extracts from demyelinating foci and with other lipid posessing antigens in multiple sclerosis. Critical studies including clincal control groups].
    Roemer GB; Mai K
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):370-90. PubMed ID: 4233550
    [No Abstract]   [Full Text] [Related]  

  • 27. [Concentric demyelinating leukoencephalitis of the Baló type with symptomatology and clinical evolution of multiple sclerosis; (anatomoclinical case)].
    Cîmpeanu E; Papilian VV; Serban M; Mareş V
    Neurol Psihiatr Neurochir; 1965; 10(4):359-64. PubMed ID: 5864370
    [No Abstract]   [Full Text] [Related]  

  • 28. Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
    Lassmann H
    Brain; 2012 Oct; 135(Pt 10):2904-5. PubMed ID: 23065786
    [No Abstract]   [Full Text] [Related]  

  • 29. Viruses isolated from patients with encephalomyelitis and multiple sclerosis. I. Pathogenic and antigenic properties.
    Bychkova EN
    Fed Proc Transl Suppl; 1965; 24(4):742-4. PubMed ID: 4953628
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy.
    Ro YI; Alexander CB; Oh SJ
    Muscle Nerve; 1983 May; 6(4):312-6. PubMed ID: 6306461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue culture studies of neuroelectric blocking factors.
    Seil FJ
    Adv Neurol; 1981; 31():281-8. PubMed ID: 7325045
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Multiple sclerosis.
    Br Med J; 1976 May; 1(6017):1030-1. PubMed ID: 1268540
    [No Abstract]   [Full Text] [Related]  

  • 33. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental allergic encephalomyelitis. A review.
    Rowe MJ
    Bull Los Angeles Neurol Soc; 1969 Jan; 34(1):55-66. PubMed ID: 4974423
    [No Abstract]   [Full Text] [Related]  

  • 35. Cultivation of peripheral lymphocytes of multiple sclerosis patients in the presence of basic protein and cerebrospinal fluid confirmed cases.
    Nemo GJ; Brody JA
    Neurology; 1970 Apr; 20(4):407. PubMed ID: 5535055
    [No Abstract]   [Full Text] [Related]  

  • 36. Demyelinating pattern of experimental allergic peripheral neuritis studied in vitro.
    Yonezawa T; Ishihara Y
    J Neuropathol Exp Neurol; 1968 Jan; 27(1):163-4. PubMed ID: 5656577
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
    Meyer-Rienecker H; Hitzschke B
    Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
    [No Abstract]   [Full Text] [Related]  

  • 39. [Peripheral neuritis--an experimental study].
    Yonezawa T; Ishihara Y; Sato Y; Mori T; Nakatani Y
    Saishin Igaku; 1968 Nov; 23(11):2281-8. PubMed ID: 4304318
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunogenesis of demyelinizing plaque in multiple sclerosis].
    Lumsden CE
    Rev Med Liege; 1972 Aug; 27(16):521-37. PubMed ID: 5052714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.